Martin Aringer

Active 1994–2025

110
Papers
33,852
Citations
70
h-index
104
i10-index

Citations

Citations per year for Martin Aringer1984: 1 citations1994: 1 citations1995: 1 citations1996: 3 citations1997: 4 citations1998: 7 citations1999: 12 citations2000: 32 citations2001: 40 citations2002: 35 citations2003: 49 citations2004: 38 citations2005: 44 citations2006: 55 citations2007: 43 citations2008: 62 citations2009: 93 citations2010: 92 citations2011: 107 citations2012: 118 citations2013: 108 citations2014: 142 citations2015: 175 citations2016: 187 citations2017: 226 citations2018: 235 citations2019: 1,054 citations2020: 1,387 citations2021: 1,409 citations2022: 1,209 citations2023: 755 citations2024: 1,285 citations2025: 528 citations2026: 17 citations1985–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,317 citing papers, 15.9% of this breakdownUnited Kingdom: 1,130 citing papers, 7.7% of this breakdownChina: 1,028 citing papers, 7% of this breakdownItaly: 949 citing papers, 6.5% of this breakdownGermany: 848 citing papers, 5.8% of this breakdownFrance: 694 citing papers, 4.7% of this breakdownNetherlands: 628 citing papers, 4.3% of this breakdownJapan: 571 citing papers, 3.9% of this breakdownSpain: 493 citing papers, 3.4% of this breakdownCanada: 492 citing papers, 3.4% of this breakdownSweden: 352 citing papers, 2.4% of this breakdownAustralia: 335 citing papers, 2.3% of this breakdown
0%15.9%Other 32.7%

Fields

  • Medicine79.8%
  • Biochemistry, Genetics and Molecular Biology9.9%
  • Immunology and Microbiology6.8%
  • Neuroscience1%
  • Health Professions0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Other1.7%

Topics

  • Systemic Lupus Erythematosus Research11.5%
  • Rheumatoid Arthritis Research and Therapies10.7%
  • Systemic Sclerosis and Related Diseases3.8%
  • Autoimmune and Inflammatory Disorders Research3.4%
  • Spondyloarthritis Studies and Treatments3.1%
  • T-cell and B-cell Immunology2.4%
  • Other65.1%

Coauthors

All papers

Open in search
  1. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y K Onno Teng, Anǵela Tincani, Edward M Vital, Ronald van Vollenhoven, Chris Wincup, George Βertsias, Dimitrios T. Boumpas - Annals of the Rheumatic Diseases 2023 cited by 933

  2. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sara K. Tedeschi, Zahi Touma, Gabriela Schmajuk, Branimir Anić, Florence Assan, Tak Mao Chan, Ann E. Clarke, Mary K. Crow, László Czirják, Andrea Doria, W. Graninger, Bernadett Halda-Kiss, Sarfaraz Hasni, Peter Izmirly, Michelle Jung, Gabór Kumánovics, Xavier Mariette, Ivan Padjen, José María Pego‐Reigosa, Juanita Romero‐Díaz, Íñigo Rúa‐Figueroa Fernández, Raphaèle Séror, Georg Stummvoll, Yoshiya Tanaka, Maria G. Tektonidou, Carlos Vasconcelos, Edward M Vital, Daniel J. Wallace, Şule Yavuz, Pier Luigi Meroni, Marvin J. Fritzler, Ray Naden, Thomas Dörner, Sindhu R. Johnson - Annals of the Rheumatic Diseases 2019 cited by 2,515

  3. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 2,017

  4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 cited by 5,775

  5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 cited by 2,766

  6. 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 cited by 807

  7. Trial of Tocilizumab in Giant-Cell Arteritis

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 1,375

  8. 2021 DORIS definition of remission in SLE: final recommendations from an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Faria, Rebecca S. B. Fischer, Ruth Fritsch‐Stork, Murat İnanç, Søren Jacobsen, David Jayne, Annegret Kuhn, Bernadette van Leeuw, Maarten Limper, Xavier Mariette, Sandra Navarra, Mandana Nikpour, Marzena Olesińska, Guillermo Pons‐Estel, Juanita Romero‐Díaz, Blanca Rubio, Y Schoenfeld, Eloísa Bonfá, Josef S Smolen, Y K Onno Teng, Anǵela Tincani, Michel Tsang-A-Sjoe, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharhova, Cynthia Aranow - Lupus Science & Medicine 2021 cited by 349

  9. Update of EULAR recommendations for the treatment of systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Tyndall, Joep Welling, F Wigley, Gabriele Valentini, Ulrich A. Walker, Francesco Zulian, Ulf Müller‐Ladner, Thomas Daikeler, Elisabetta Lanciano, Radim Bečvář, Michal Tomcik, Ewa Gińdzieńska-Sieśkiewicz, Giovanna Cuomo, Michele Iudici, Simona Rednic, Panayiotis G. Vlachoyiannopoulos, Roberto Caporali, Patricia E. Carreira, Servicio de Reumatología, Srdan Novak, Tünde Minier, Eugene J. Kucharz, Armando Gabrielli, Gianluca Moroncini, Paolo Airo', Roger Hesselstrand, Duska Martinovic, Mislav Radić, Daniela Marasovic-Krstulovic, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Andrea Lo Monaco, Paola Caramaschi, Jadranka Morović-Vergles, Melanie I. Čulo, Jörg Henes, Vera Ortiz Santamaria, Stefan Heitmann, Dorota Krasowska, Małgorzata Michalska-Jakubus, Matthias F. Seidel, Paul Hasler, Klinik für Rheumatologie, José A. Pereira Da Silva, Maria J. Salvador, Bojana Stamenkovic, Aleksandra Stankovic, Mohammed Tikly, Lidia P. Ananieva, Lorenzo Beretta, Gabriella Szucs, Szilvia Szamosi, Carlos de la Puente Bujidos, Servicio de Reumatología, Øyvind Midtvedt, Anna-Maria Hoffmann-Vold, David Launay, Eric Hachulla, Valeria Riccieri, Ruxandra Ionescu, Daniela Opris, Carina Mihai, Ilka Herrgott, Christian Beyer, Francesca Ingegnoli, Carlos Alberto von Mühlen, Juan José Alegre-Sancho, Emma Beltrán-Catalán, Martin Aringer, Julia Fantana and 35 more - Annals of the Rheumatic Diseases 2016 cited by 1,116

  10. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Kouloumas, Robert Landewé, E. Martín‐Mola, Peter Nash, Mikkel Østergaard, Andrew J.K. Östör, P. Scott Richards, Tuulikki Sokka‐Isler, Carter Thorne, Athanasios G. Tzioufas, Ronald van Vollenhoven, M. De Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2015 cited by 1,458

  11. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jozef Rovenský, Josef S Smolen, Carlos Vasconcelos, Alexandre E. Voskuyl, Anne Voss, Elena Zakharova, Asad Zoma, Matthias Schneider - Annals of the Rheumatic Diseases 2014 cited by 727

  12. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Véronique Le Guern, Kirsten Lerstrøm, Roger A. Levy, Francinne Machado-Ribeiro, Xavier Mariette, Jamil Missaykeh, Eric F. Morand, Marta Mosca, Murat İnanç, Sandra Navarra, Irmgard Neumann, Marzena Olesińska, Michelle Petri, Anisur Rahman, Ole Petter Rekvig, Jozef Rovenský, Yehuda Shoenfeld, Josef S Smolen, Anǵela Tincani, Murray B. Urowitz, Bernadette van Leeuw, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharova, Asad Zoma, Matthias Schneider, Michael M. Ward - Annals of the Rheumatic Diseases 2016 cited by 357

  13. Inflammatory markers in systemic lupus erythematosus

    Authors: - Journal of Autoimmunity 2019 cited by 211

  14. Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort

    Authors: , , , , , , , - Lupus 2021 cited by 108

  15. Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial

    Authors: , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2022 cited by 114

  16. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louise A. Donnelly, Lynette D. Fairbanks, Martin Aringer, Paul McKeigue, Stuart H. Ralston, Andrew D. Morris, Pavao Rudan, Nicholas D. Hastie, Harry Campbell, Alan F. Wright - Nature Genetics 2008 cited by 806

  17. Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial

    Authors: , , , , , - Clinical Rheumatology 2023 cited by 76

  18. Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. A. Hitman, John J. O’Shea, Daniel L. Kastner - Cell 1999 cited by 1,421

  19. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 727

  20. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabriela Riemekasten, Simona Rednic, Edoardo Rosato, Marta Saracco, A Scheja, Vanessa Smith, Carina Mihai, Gabriela Szucs, Matija Tomšič, Gabriele Valentini, Ulrich A. Walker, R Westhovens, Şule Yavuz, Thierry Zénone - Annals of the Rheumatic Diseases 2014 cited by 428

  21. Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial

    Authors: , , , , , , , , , , , - The Lancet Rheumatology 2021 cited by 133

  22. Defective removal of ribonucleotides from DNA promotes systemic autoimmunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Markus M. Nöthen, Martin Aringer, Annegret Kuhn, Kirsten Lüthke, L. Unger, Annette Bley, Alice Lorenzi, John D. Isaacs, Dimitra Alexopoulou, Karsten Conrad, Andreas Dahl, Axel Roers, Marta E. Alarcón‐Riquelme, Andrew P. Jackson, Min Ae Lee-Kirsch - Journal of Clinical Investigation 2014 cited by 222

  23. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Jayne, Dimitrios T. Boumpas - Annals of the Rheumatic Diseases 2012 cited by 1,026

  24. Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial

    Authors: , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2024 cited by 53